Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Argos Therapeutics Company Profile (NASDAQ:ARGS)

Consensus Ratings for Argos Therapeutics (NASDAQ:ARGS) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $14.75 (65.54% upside)

Analysts' Ratings History for Argos Therapeutics (NASDAQ:ARGS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/31/2015MLV & Co.Reiterated RatingBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
3/26/2015Roth CapitalInitiated CoverageBuy$21.00ViewTweet This Rating  Share This Rating on StockTwits
3/22/2015ZacksReiterated RatingHold -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/25/2015MLV & Co.Initiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2014ZacksDowngradeNeutral$9.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Stifel NicolausInitiated CoverageBuy -> Buy$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Piper JaffrayInitiated CoverageOverweight$18.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014JMP SecuritiesInitiated CoverageOutperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Needham & Company LLCInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/31/2013 forward)